Parsey Merdad 4

What Happened

• Parsey Merdad, a director of Ardelyx, Inc. (ARDX), received equity compensation on 2026-06-16. The Form 4 reports two grants: 26,455 restricted stock units (RSUs) and a 39,715‑share derivative award (an option-like award). Both grants show an acquisition price of $0.00 (standard for compensation awards); total cash paid = $0. These awards were issued under the issuer’s Non‑Employee Director Compensation Program and were reported on Form 4 filed 2026-06-18.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (timely; within typical two-business-day reporting window).
• Grant types and amounts: 26,455 RSUs (F1) and 39,715 derivative award/option (A, F2).
• Price: $0.00 per share for both awards (compensation grant, not a purchase).
• Shares owned after transaction: not specified in the provided filing information.
• Footnotes of note:
  • F1: RSUs convert to one share of common stock per RSU upon vesting.
  • F2/F3: The derivative award is an option issued under the director program; it vests 1/12th monthly and will fully accelerate on the date of the next annual stockholder meeting to the extent unvested, subject to continued service.
• Exhibit included: 24.1 — Power of Attorney.

Context

• RSUs and option grants are routine director compensation and do not represent an open‑market purchase (which some investors view as a more direct bullish signal). RSUs convert to shares only upon vesting; the derivative award is subject to a monthly vesting schedule with potential acceleration at the next annual meeting. These grants are compensation-focused and should be interpreted accordingly rather than as a near‑term insider buy/sell signal.